Detailed answers about LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED, including incorporation, status, business activity, and accounts information.
When was LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED founded?
LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED was officially incorporated on 24 February 2022 and is registered under company number 13939130. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED?
LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED do?
LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED's registered address?
The registered office address of LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED is THE MILLS, CANAL STREET, DERBY, DERBYSHIRE, ENGLAND, DE1 2RJ. This is the official address filed with Companies House for legal and statutory correspondence.
Is LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED financially stable?
The most recent accounts for LONDON INTERNATIONAL ENDOCRINE CLINIC LIMITED were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.